Temporally controlled prostate epithelium-specific gene alterations.

H Artee Luchman1, Hana C Friedman, Michelle L Villemaire

  • 1Department of Biochemistry and Molecular Biology, The McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, Canada.

Genesis (New York, N.Y. : 2000)
|April 9, 2008
PubMed
Summary

Researchers developed a new mouse model for studying prostate cancer. This tamoxifen-inducible Cre-ER(T2) system allows precise control over gene alterations in prostate cells, aiding research into prostate tumorigenesis.

Related Concept Videos